Vaccination

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	11

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

trials per page:

Showing 1 to 10 of 11 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04839315 (ClinicalTrials.gov)	February 15, 2021	5/4/2021	COVID-19 Vaccination in Rheumatic Disease Patients	Immunological Consequences of COVID-19 Vaccination in Patients With Rheumatic Diseases	Systemic Lupus Erythematosus;Sjogren's Syndrome;Inflammatory Myositis;Psoriatic Arthritis;Gout;Ankyl ...	Biological: mRNA COVD19 vaccine	Mayo Clinic	NULL	Terminated	18 Years	N/A	All	58	Early Phase 1	United States
2	NCT02477254 (ClinicalTrials.gov)	July 2015	17/6/2015	Long-term Immunogenicity of a HPV Vaccine in SLE	Long-term Immunogenicity of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With Syste ...	Systemic Lupus Erythematosus	Biological: Vaccination	Tuen Mun Hospital	NULL	Completed	18 Years	35 Years	Female	84	N/A	China
3	NCT01687192 (ClinicalTrials.gov)	October 2012	13/9/2012	Multicenter Trial Evaluating the Immunogenicity of HPV Vaccinationin Girls on Immunosuppressive Ther ...	Multicenter Clinical Trial Evaluating the Immunological Response of VaccinationAgainst Infection by ...	Transplantation;Systemic Lupus Erythematosus;Systemic Immune Disease	Biological: HPV prophylactic vaccine Gardasil	University Hospital, Bordeaux	NULL	Active, not recruiting	9 Years	18 Years	Female	37	Phase 2	France
4	NCT01597492 (ClinicalTrials.gov)	May 31, 2012	8/5/2012	A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Ery ...	A Phase 4, Multi-Center, Randomized, Open-Label Study to Evaluate the Effect of BENLYSTA™ (Belimumab ...	Systemic Lupus Erythematosus	Biological: Belimumab plus Early Vaccination;Biological: Belimumab plus Late Vaccination	Human Genome Sciences Inc., a GSK Company	GlaxoSmithKline	Completed	18 Years	N/A	All	79	Phase 4	United States
5	NCT01474720 (ClinicalTrials.gov)	November 2011	15/11/2011	Zostavax in Systemic Lupus Erythematosus	Immunologic Response to Varicella Zoster VaccinationWith Zostavax in Patients With Systemic Lupus Er ...	Systemic Lupus Erythematosus	Drug: Zostavax vaccine	Oklahoma Medical Research Foundation	NULL	Completed	50 Years	75 Years	Both	20	Phase 1	United States
6	NCT01151644 (ClinicalTrials.gov)	April 2010	25/6/2010	Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases	Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases	Rheumatoid Arthritis;Spondyloarthritis;Systemic Lupus Erythematosus (SLE);Dermatomyositis (DM);DMixe ...	Biological: Anti-pandemic H1N1 influenza vaccine	University of Sao Paulo	Fundação de Amparo à Pesquisa do Estado de São Paulo	Active, not recruiting	N/A	N/A	Both	5000	Phase 4	Brazil
7	NCT01006681 (ClinicalTrials.gov)	November 2009	31/10/2009	Vaccination Against Influenza H1N1 in Rheumatic Diseases	Efficacy and Safety of VaccinationAgainst Influenza H1N1 in Patients With Rheumatoid Arthritis, Syst ...	Influenza;Rheumatic Diseases	Biological: Focetria (Monovalent MF59-Adjuvanted vaccine)	Tel-Aviv Sourasky Medical Center	NULL	Not yet recruiting	18 Years	65 Years	Both	400	Phase 2	NULL
8	NCT00911521 (ClinicalTrials.gov)	October 2009	28/5/2009	Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: ...	Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With Syst ...	Systemic Lupus Erythematosus	Drug: human papillomavirus vaccination (Gardasil)	Tuen Mun Hospital	NULL	Completed	N/A	35 Years	Female	100	Phase 4	China
9	EUCTR2008-008169-36-NL (EUCTR)	17/02/2009	29/12/2008	Immune response after Human Papillomavirus vaccinationin patients with auto-immune disease - HPV stu ...	Immune response after Human Papillomavirus vaccinationin patients with auto-immune disease - HPV stu ...	Juvenile Idiopathic ArthritisSystemic lupus erythematosus childhood dermatomyositis MedDRA version: ...	Trade Name: Cervarix suspensie voor injectie Product Name: not applicable Product Code: not applicable ...	University Medical Center Utrecht	NULL	Not Recruiting			Female: yes Male: no			Netherlands
10	NCT00611663 (ClinicalTrials.gov)	May 2008	28/1/2008	Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus	VACCILUP A Multicenter, Randomized Double-blind Trial Comparing Two Pneumococcal VaccinationStrategi ...	Lupus Erythematosus, Systemic	Biological: Prevenar® and Pneumo23®;Biological: Placebo, Pneumo23®	Assistance Publique - Hôpitaux de Paris	NULL	Completed	18 Years	65 Years	Both	47	Phase 2/Phase 3	France

First Previous1 2Next Last